Early-Life Microbiome

Analyzing the gut microbiomes of children from birth through toddlerhood, researchers tie compositional changes to birth mode, infant diet, and antibiotic therapy.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

V. ALTOUNIAN/SCIENCE TRANSLATIONAL MEDICINEAnalyzing stool samples from 39 children in Finland for the first three years of their lives, a team led by investigators at the Broad Institute monitored the effects of factors including birth mode (vaginal versus Cesarean-section delivery) and the administration of antibiotics. Bacteroides bacteria dominated the gut microbiomes of most children born vaginally, while those born by C-section—and some of the vaginally delivered children—lacked Bacteroides for the first 6 to 18 months of their lives, the researchers reported yesterday (June 15) in Science Translational Medicine. Early-life antibiotic therapy was associated with less-diverse microbial communities overall, the researchers showed, and the 20 children who were treated with these drugs (for respiratory or ear infections) harbored antibiotic-resistance genes on microbial chromosomes and in mobile elements, some of which persisted beyond the completion of treatment.

“Regardless of their origin, our data suggest that the genomic context of the antibiotic resistance gene may influence its spread and persistence upon exposure to antibiotics,” the authors wrote in their paper. “Given the growing prevalence of antibiotic treatments and the frequency at which children exchange microbiota, it is particularly important to understand the effects of childhood antibiotic exposure on the presence and spread of antibiotic resistance genes in the community.”

Meanwhile, a team led by researchers at New York University (NYU) reported its analysis of microbiome development across 43 children in the U.S. for the first two years of the children’s lives. The team’s results, published yesterday in the same journal, show that birth mode, antibiotic treatment, and diet (breast milk– versus formula-dominant) all ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform